Shorter reflections, LinkedIn series, and commentary on events, trends, and questions we encounter in our daily work. With the occasional book spotlight. Think of this as our notebook — where ongoing questions meet fresh observations.
Spotting the Next Gullwing: How to Distinguish Breakthrough Biotech from Concept Hype
I’ve always admired the Mercedes 300 SL Gullwing. This wasn’t just a beautiful car – it represented radical engineering leaps. Fuel injection, lightwe…
3 common mistakes in pharma market access negotiations – and how to avoid them
Market access is often the decisive bottleneck: without successful payer negotiations, even the most innovative product will fail commercially. From m…
Asia-Pacific BioPharma Insights
Country Spotlight Series: Japan Biotech & Pharma Deep Dive Market Overview Japan is one of the most mature and innovation-driven biotech and pharm…
Negotiations in Biotech
In biotech, most negotiations are won or lost long before the first offer is made. After 25+ years as a founder, pharma exec, and investor, I’ve learn…
What restoring a classic car taught me about consulting
In my free time, I restore old Mercedes-Benz cars – such as the R107 SL model. It’s not fast. It’s not efficient. But it teaches me things that …
Book Spotlight: Strategic Negotiations
Negotiations aren’t isolated events. They happen within a context of complex strategic interactions, organizational interests, and evolving relationsh…